A posterior expected value approach to decision-making in the multiphase optimization strategy for intervention
Jillian C Strayhorn1, Linda M Collins2, David J Vanness3
1Department of Human Development and Family Studies, Pennsylvania State University.
A new Bayesian decision theory approach for intervention optimization significantly improves accuracy over traditional methods. This posterior expected value approach enhances component selection in factorial trials for better intervention development.
Area of Science:
- Behavioral Science
- Health Intervention Science
- Biostatistics
Background:
- Current intervention optimization relies on component screening approach (CSA) in factorial trials.
- CSA involves identifying significant main effects and interactions based on fixed thresholds for component selection.
Purpose of the Study:
- To introduce and evaluate a posterior expected value approach for intervention component selection.
- To compare the performance of the posterior expected value approach against CSA and traditional benchmarks.
Main Methods:
- Monte Carlo simulations were used to assess the performance of the posterior expected value approach and CSA.
- Evaluated approaches against random selection and classical treatment package benchmarks.
- Simulations incorporated realistic variations in factorial optimization trials.
Main Results:
- Both posterior expected value approach and CSA demonstrated substantial performance gains over benchmarks.
- The posterior expected value approach showed modest but consistent superiority over CSA in accuracy, sensitivity, and specificity.
- Performance improvements were observed across various simulated trial conditions.
Conclusions:
- The posterior expected value approach offers a more accurate and extensible method for intervention optimization within the multiphase optimization strategy (MOST).
- This Bayesian decision theory-based method provides practical advantages for selecting intervention components in factorial trials.
- Future research should explore further applications of the posterior expected value approach in intervention design and decision-making.
More Related Videos
11:53Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm
Published on: December 9, 2012
06:00Optimization of the Epimedii Folium Mutton-Oil Processing Technology and Testing Its Effect on Zebrafish Embryonic Development
Published on: March 17, 2023
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
